Across TCGA pan-cancer cohorts, MIR548H1 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of MIR548H1’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where MIR548H1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR548H1 is over-expressed in tumor, although a few such as LUSC show the opposite, repressed pattern.

STAD, BLCA, and READ are the cancer types where MIR548H1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR548H1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	II,III,IV	+0.388	.003	5	view →
BLCA	All	III,IV	+0.349	.041	3	view →
READ	All	All	+0.485	.028	2	view →
HNSC	All	All	+0.095	.025	2	view →
LUSC	All	II,III,IV	−0.207	.041	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: MIR548H1 RNA expression & survival · all MIR548H1 data types